544,698 Shares in Shire PLC (SHPG) Acquired by Jana Partners LLC

Jana Partners LLC acquired a new position in Shire PLC (NASDAQ:SHPG) during the first quarter, Holdings Channel reports. The institutional investor acquired 544,698 shares of the biopharmaceutical company’s stock, valued at approximately $94,903,000. Shire PLC comprises 1.8% of Jana Partners LLC’s investment portfolio, making the stock its 19th largest position.

A number of other institutional investors also recently made changes to their positions in SHPG. Dumont & Blake Investment Advisors LLC increased its position in shares of Shire PLC by 0.3% in the first quarter. Dumont & Blake Investment Advisors LLC now owns 2,594 shares of the biopharmaceutical company’s stock worth $452,000 after buying an additional 7 shares during the last quarter. Bienville Capital Management LLC increased its position in shares of Shire PLC by 0.4% in the fourth quarter. Bienville Capital Management LLC now owns 2,453 shares of the biopharmaceutical company’s stock worth $418,000 after buying an additional 9 shares during the last quarter. Level Four Advisory Services LLC increased its position in shares of Shire PLC by 0.5% in the first quarter. Level Four Advisory Services LLC now owns 2,745 shares of the biopharmaceutical company’s stock worth $480,000 after buying an additional 13 shares during the last quarter. Thompson Davis & CO. Inc. increased its position in shares of Shire PLC by 3.1% in the first quarter. Thompson Davis & CO. Inc. now owns 640 shares of the biopharmaceutical company’s stock worth $112,000 after buying an additional 19 shares during the last quarter. Finally, Macquarie Group Ltd. increased its position in shares of Shire PLC by 2.2% in the fourth quarter. Macquarie Group Ltd. now owns 1,417 shares of the biopharmaceutical company’s stock worth $241,000 after buying an additional 31 shares during the last quarter. Hedge funds and other institutional investors own 21.28% of the company’s stock.

Institutional Ownership by Quarter for Shire PLC (NASDAQ:SHPG)

Shire PLC (NASDAQ:SHPG) traded up 1.46% on Friday, reaching $164.72. The company had a trading volume of 1,542,468 shares. The stock’s 50-day moving average price is $177.60 and its 200 day moving average price is $174.28. Shire PLC has a 52-week low of $161.09 and a 52-week high of $209.22. The firm has a market capitalization of $49.06 billion, a price-to-earnings ratio of 168.94 and a beta of 1.57.

Shire PLC (NASDAQ:SHPG) last posted its earnings results on Tuesday, May 2nd. The biopharmaceutical company reported $3.63 EPS for the quarter, topping the consensus estimate of $3.22 by $0.41. Shire PLC had a net margin of 2.14% and a return on equity of 13.05%. The business had revenue of $3.57 billion for the quarter. During the same quarter in the prior year, the business earned $2.12 earnings per share. The firm’s quarterly revenue was up 109.0% on a year-over-year basis. On average, equities analysts anticipate that Shire PLC will post $14.90 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This article was first reported by sleekmoney and is owned by of sleekmoney. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international copyright law. The legal version of this article can be read at https://sleekmoney.com/544698-shares-in-shire-plc-shpg-acquired-by-jana-partners-llc/1916328.html.

A number of brokerages recently commented on SHPG. Jefferies Group LLC set a $239.00 price objective on Shire PLC and gave the stock a “buy” rating in a research report on Saturday, March 18th. Cowen and Company reiterated an “outperform” rating and set a $325.00 price objective on shares of Shire PLC in a research report on Wednesday, May 31st. Cantor Fitzgerald began coverage on Shire PLC in a research note on Friday. They set an “overweight” rating and a $222.00 target price for the company. BidaskClub cut Shire PLC from a “sell” rating to a “strong sell” rating in a research note on Friday. Finally, ValuEngine cut Shire PLC from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and sixteen have assigned a buy rating to the stock. Shire PLC currently has a consensus rating of “Buy” and an average target price of $223.01.

About Shire PLC

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Want to see what other hedge funds are holding SHPG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shire PLC (NASDAQ:SHPG).

This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/544698-shares-in-shire-plc-shpg-acquired-by-jana-partners-llc/1916328.html

Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *